Molina JM, Ene L, Cahn P, Fatkenheuer G, et al. Long-term safety and efficacy of rilpivirine in combination with
nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected
patients: 336-week rollover study of phase 2b and 3 clinical studies. Antivir Ther 2021;26.
PMID: 35485339